» Articles » PMID: 10692992

Hypodense Alveolar Macrophages in Patients with Diabetes Mellitus and Active Pulmonary Tuberculosis

Overview
Journal Tuber Lung Dis
Specialty Pulmonary Medicine
Date 2000 Feb 29
PMID 10692992
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Setting: Alveolar macrophages (AM), a heterogeneous cell population, play a critical role in eliminating mycobacterial infections in collaboration with lymphocytes. Patients with diabetes mellitus (DM) show increased susceptibility to pulmonary tuberculosis (TB) infection. It is still uncertain whether there is a defect in T cell or AM activation in patients with DM against TB infection.

Objective: To study the difference in activation status of AM and T cells between patients with TB + DM and TB alone.

Method: The heterogeneity of AM from 14 patients with TB + DM, 9 with TB alone, 10 normal subjects and 8 DM alone patients, was studied using Percoll density fractionation. The intracellular H2O2 production of AM before and after stimulation with phorbol myristate acetate (PMA) or F-Met-Leu-Phen (FMLP) was assayed by loading cells with 2',7'-dichlorofluorescin (DCFH) and analyzed by flow cytometry. Lymphocytes subsets (CD3, CD4, CD8) and their activation status (CD25) in bronchoalveolar lavage were also measured.

Results: The proportion of the least dense AM (< 1,030 g/ml) and the magnitude of DCFH oxidation of AM was higher in TB patients than in normal subjects, regardless of DM. Patients with TB + DM had a significantly lower proportion of the least density AM fraction than TB alone patients, regardless of disease extent. Among TB patients, the proportion of the least dense AM was inversely correlated with the bacterial load on sputum and the disease extent on chest radiograph. Stimulation of AM with PMA or FMLP induced an increase in the hypodense AM subpopulations and enhanced intracellular H2O2 generation in patients with TB + DM and to a similar extent in normal subjects, but not in patients with TB alone. There was no significant difference in CD3 numbers, CD4/CD8 ratio, and CD25+ cells between patients with TB alone and TB + DM. The activation status of AM or T lymphocytes from DM alone patients was not significantly different from those from normal subjects.

Conclusion: Hypodense subpopulations of AM increase in active TB patients and are related to the disease severity as well as activation status of AM. AM in TB patients complicated with DM was less activated, and may be contributory to the susceptibility to mycobacterial infection.

Citing Articles

The association between triglyceride-glucose index and related parameters and risk of tuberculosis infection in American adults under different glucose metabolic states: a cross-sectional study.

Qi M, Qiao R, He J BMC Public Health. 2025; 25(1):966.

PMID: 40069759 PMC: 11900396. DOI: 10.1186/s12889-025-21793-6.


Frequency and Predictors of Diabetes Mellitus in Smear-Positive Pulmonary Tuberculosis Patients: A Cross-Sectional Study.

Baqi A, Sumalani K, Akhter N, Ahmed M, Ahmed K, Chawla D Cureus. 2025; 16(12):e75809.

PMID: 39816303 PMC: 11734866. DOI: 10.7759/cureus.75809.


Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?.

Aravindhan V, Yuvaraj S Front Endocrinol (Lausanne). 2024; 15:1303338.

PMID: 38327565 PMC: 10848915. DOI: 10.3389/fendo.2024.1303338.


Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial.

Tamez-Torres K, Mongua-Rodriguez N, Ferreyra-Reyes L, Torres-Gonzalez P, Delgado-Sanchez G, Martinez-Hernandez M Microorganisms. 2023; 11(8).

PMID: 37630477 PMC: 10459081. DOI: 10.3390/microorganisms11081917.


[Epidemiologic-clinical, biological and radiological features of pulmonary tuberculosis in patients with diabetes in Antananarivo, Madagascar].

Andrianiaina M, Raherison R, Razanamparany T, Raharinavalona S, Rakotomalala A, Andrianasolo R Pan Afr Med J. 2022; 42:49.

PMID: 35949462 PMC: 9338721. DOI: 10.11604/pamj.2022.42.49.29199.